Stay updated on Sotorasib in KRAS G12C NSCLC Clinical Trial

Sign up to get notified when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sotorasib in KRAS G12C NSCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T03:06:03.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Added a Locations section with Pennsylvania (Philadelphia) as a trial site and updated the page revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the older Pennsylvania Locations entry (v3.3.2).
    Difference
    0.3%
    Check dated 2025-12-23T22:06:06.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    The page shows a new revision tag: v3.3.2, replacing v3.2.0. No substantive changes to trial information are evident.
    Difference
    0.1%
    Check dated 2025-11-25T11:48:20.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page no longer displays the government funding status notice; there are no changes to trial details, eligibility criteria, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:14:41.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The new screenshot shows minor layout and styling updates with no substantive changes to the study details (inclusion criteria, primary outcome, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:18:02.000Z thumbnail image
  8. Check
    111 days ago
    Change Detected
    Summary
    Overall, the page updates to v3.2.0 and adds a government-operating-status notice; the prior v3.1.0 reference was removed.
    Difference
    4%
    Check dated 2025-10-06T05:53:44.000Z thumbnail image

Stay in the know with updates to Sotorasib in KRAS G12C NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sotorasib in KRAS G12C NSCLC Clinical Trial page.